Wang, Ju <br/><br/>
Antitumor activity of a recombinant soluble ectodomain of mutant human fibroblast growth factor receptor-2 IIIc.  [electronic resource] 

 -  Molecular cancer therapeutics  Sep 2011 
 - 1656-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-11-0163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Transformed<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Ligands<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mutant Proteins--genetics<br/>NIH 3T3 Cells<br/>Neoplasm Metastasis--drug therapy<br/>Neoplasms--drug therapy<br/>Neovascularization, Physiologic--drug effects<br/>Peptide Fragments--chemistry<br/>Protein Binding<br/>Receptor, Fibroblast Growth Factor, Type 2--chemistry<br/>Recombinant Proteins--chemistry<br/>Signal Transduction--drug effects<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays